PER3 Polymorphism Predicts Cumulative Sleep Homeostatic but Not Neurobehavioral Changes to Chronic Partial Sleep Deprivation

被引:109
作者
Goel, Namni
Banks, Siobhan
Mignot, Emmanuel
Dinges, David F.
机构
[1] Division of Sleep and Chronobiology, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA
[2] Center for Narcolepsy, Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, CA
[3] Centre for Sleep Research, University of South Australia, Adelaide, SA
来源
PLOS ONE | 2009年 / 4卷 / 06期
关键词
INTERINDIVIDUAL DIFFERENCES; INDIVIDUAL-DIFFERENCES; LENGTH POLYMORPHISM; PERFORMANCE; RESTRICTION; GENE; ASSOCIATION; WAKEFULNESS; PHYSIOLOGY; DISSOCIATION;
D O I
10.1371/journal.pone.0005874
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The variable number tandem repeat (VNTR) polymorphism 5-repeat allele of the circadian gene PERIOD3 (PER3(5/5)) has been associated with cognitive decline at a specific circadian phase in response to a night of total sleep deprivation (TSD), relative to the 4-repeat allele (PER3(4/4)). PER3(5/5) has also been related to higher sleep homeostasis, which is thought to underlie this cognitive vulnerability. To date, no study has used a candidate gene approach to investigate the response to chronic partial sleep deprivation (PSD), a condition distinct from TSD and one commonly experienced by millions of people on a daily and persistent basis. We evaluated whether the PER3 VNTR polymorphism contributed to cumulative neurobehavioral deficits and sleep homeostatic responses during PSD. Methodology/Principal Findings: PER3(5/5) (n = 14), PER3(4/5) (n = 63) and PER3(4/4) (n = 52) healthy adults (aged 22-45 y) demonstrated large, but equivalent cumulative decreases in cognitive performance and physiological alertness, and cumulative increases in sleepiness across 5 nights of sleep restricted to 4 h per night. Such effects were accompanied by increasing daily inter-subject variability in all groups. The PER3 genotypes did not differ significantly at baseline in habitual sleep, physiological sleep structure, circadian phase, physiological sleepiness, cognitive performance, or subjective sleepiness, although during PSD, PER3(5/5) subjects had slightly but reliably elevated sleep homeostatic pressure as measured physiologically by EEG slow-wave energy in non-rapid eye movement sleep compared with PER3(4/4) subjects. PER3 genotypic and allelic frequencies did not differ significantly between Caucasians and African Americans. Conclusions/Significance: The PER3 VNTR polymorphism was not associated with individual differences in neurobehavioral responses to PSD, although it was related to one marker of sleep homoeostatic response during PSD. The comparability of PER3 genotypes at baseline and their equivalent inter-individual vulnerability to sleep restriction indicate that PER3 does not contribute to the neurobehavioral effects of chronic sleep loss.
引用
收藏
页数:13
相关论文
共 53 条
[1]   SUBJECTIVE AND OBJECTIVE SLEEPINESS IN THE ACTIVE INDIVIDUAL [J].
AKERSTEDT, T ;
GILLBERG, M .
INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1990, 52 (1-2) :29-37
[2]  
[Anonymous], 2008, 2008 sleep in America poll
[3]   A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference [J].
Archer, SN ;
Robilliard, DL ;
Skene, DJ ;
Smits, M ;
Williams, A ;
Arendt, J ;
von Schantz, M .
SLEEP, 2003, 26 (04) :413-415
[4]  
Banks S, 2007, J CLIN SLEEP MED, V3, P519
[5]   AN INVENTORY FOR MEASURING DEPRESSION [J].
BECK, AT ;
ERBAUGH, J ;
WARD, CH ;
MOCK, J ;
MENDELSOHN, M .
ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) :561-&
[6]   Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study [J].
Belenky, G ;
Wesensten, NJ ;
Thorne, DR ;
Thomas, ML ;
Sing, HC ;
Redmond, DP ;
Russo, MB ;
Balkin, TJ .
JOURNAL OF SLEEP RESEARCH, 2003, 12 (01) :1-12
[7]  
Benton A., 1976, Multilingual aphasia examination
[8]  
Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI [DOI 10.1080/13854048908403285, 10.1080/13854048908403285]
[9]   Age and individual variability in performance during sleep restriction [J].
Bliese, Paul D. ;
Wesensten, Nancy J. ;
Balkin, Thomas J. .
JOURNAL OF SLEEP RESEARCH, 2006, 15 (04) :376-385
[10]   Pharmacogenetics of Modafinil After Sleep Loss: Catechol-O-Methyltransferase Genotype Modulates Waking Functions But Not Recovery Sleep [J].
Bodenmann, S. ;
Xu, S. ;
Luhmann, U. F. O. ;
Arand, M. ;
Berger, W. ;
Jung, H. H. ;
Landolt, H. P. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (03) :296-304